• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东呼吸综合征冠状病毒的流行病学和进化:2012-2020 年。

Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012-2020.

机构信息

Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 West Wenhua Road, Jinan, People's Republic of China.

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing, 100071, People's Republic of China.

出版信息

Infect Dis Poverty. 2021 May 8;10(1):66. doi: 10.1186/s40249-021-00853-0.

DOI:10.1186/s40249-021-00853-0
PMID:33964965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8105704/
Abstract

BACKGROUND

The ongoing transmission of the Middle East respiratory syndrome coronavirus (MERS-CoV) in the Middle East and its expansion to other regions are raising concerns of a potential pandemic. An in-depth analysis about both population and molecular epidemiology of this pathogen is needed.

METHODS

MERS cases reported globally as of June 2020 were collected mainly from World Health Organization official reports, supplemented by other reliable sources. Determinants for case fatality and spatial diffusion of MERS were assessed with Logistic regressions and Cox proportional hazard models, respectively. Phylogenetic and phylogeographic analyses were performed to examine the evolution and migration history of MERS-CoV.

RESULTS

A total of 2562 confirmed MERS cases with 150 case clusters were reported with a case fatality rate of 32.7% (95% CI: 30.9‒34.6%). Saudi Arabia accounted for 83.6% of the cases. Age of ≥ 65 years old, underlying conditions and ≥ 5 days delay in diagnosis were independent risk factors for death. However, a history of animal contact was associated with a higher risk (adjusted OR = 2.97, 95% CI: 1.10-7.98) among female cases < 65 years but with a lower risk (adjusted OR = 0.31, 95% CI: 0.18-0.51) among male cases ≥ 65 years old. Diffusion of the disease was fastest from its origin in Saudi Arabia to the east, and was primarily driven by the transportation network. The most recent sub-clade C5.1 (since 2013) was associated with non-synonymous mutations and a higher mortality rate. Phylogeographic analyses pointed to Riyadh of Saudi Arabia and Abu Dhabi of the United Arab Emirates as the hubs for both local and international spread of MERS-CoV.

CONCLUSIONS

MERS-CoV remains primarily locally transmitted in the Middle East, with opportunistic exportation to other continents and a potential of causing transmission clusters of human cases. Animal contact is associated with a higher risk of death, but the association differs by age and sex. Transportation network is the leading driver for the spatial diffusion of the disease. These findings how this pathogen spread are helpful for targeting public health surveillance and interventions to control endemics and to prevent a potential pandemic.

摘要

背景

中东呼吸综合征冠状病毒(MERS-CoV)在中东持续传播,并扩展至其他地区,引发了对潜在大流行的担忧。目前需要对该病原体的人群和分子流行病学进行深入分析。

方法

我们主要从世界卫生组织的官方报告中收集截至 2020 年 6 月全球报告的 MERS 病例,并辅以其他可靠来源。使用 Logistic 回归和 Cox 比例风险模型分别评估 MERS 的病死率和空间扩散决定因素。进行系统发育和系统地理学分析以检验 MERS-CoV 的进化和迁移历史。

结果

共报告了 2562 例确诊的 MERS 病例,其中有 150 例病例聚集,病死率为 32.7%(95%CI:30.9‒34.6%)。沙特阿拉伯占病例的 83.6%。年龄≥65 岁、基础疾病和≥5 天的诊断延迟是死亡的独立危险因素。然而,动物接触史与女性病例(年龄<65 岁)的死亡风险增加相关(调整后的 OR=2.97,95%CI:1.10-7.98),但与男性病例(年龄≥65 岁)的死亡风险降低相关(调整后的 OR=0.31,95%CI:0.18-0.51)。疾病的扩散速度最快的是从其起源地沙特阿拉伯向东扩散,主要是由交通网络驱动的。最近的子谱系 C5.1(自 2013 年以来)与非同义突变和更高的死亡率相关。系统地理学分析表明,沙特阿拉伯的利雅得和阿拉伯联合酋长国的阿布扎比是 MERS-CoV 本地和国际传播的中心。

结论

MERS-CoV 仍主要在中东地区局部传播,偶尔会向其他大陆输出,并有可能引起人类病例的传播集群。动物接触与更高的死亡风险相关,但这种关联因年龄和性别而异。交通网络是疾病空间扩散的主要驱动因素。这些发现有助于确定该病原体的传播方式,以便有针对性地开展公共卫生监测和干预措施,以控制地方性流行并防止潜在的大流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf6/8106118/b6c7bb015186/40249_2021_853_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf6/8106118/7e364cece8b4/40249_2021_853_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf6/8106118/984b082d39a6/40249_2021_853_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf6/8106118/b6c7bb015186/40249_2021_853_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf6/8106118/7e364cece8b4/40249_2021_853_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf6/8106118/984b082d39a6/40249_2021_853_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cf6/8106118/b6c7bb015186/40249_2021_853_Fig3_HTML.jpg

相似文献

1
Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012-2020.中东呼吸综合征冠状病毒的流行病学和进化:2012-2020 年。
Infect Dis Poverty. 2021 May 8;10(1):66. doi: 10.1186/s40249-021-00853-0.
2
Epidemiology of a Novel Recombinant Middle East Respiratory Syndrome Coronavirus in Humans in Saudi Arabia.沙特阿拉伯人类新型重组中东呼吸综合征冠状病毒的流行病学
J Infect Dis. 2016 Sep 1;214(5):712-21. doi: 10.1093/infdis/jiw236. Epub 2016 Jun 14.
3
Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia.沙特阿拉伯与 MERS 患者有过接触的动物中 MERS-CoV 特异性 RNA 和抗体的横断面研究。
J Infect Public Health. 2018 May-Jun;11(3):331-338. doi: 10.1016/j.jiph.2017.09.022. Epub 2017 Oct 6.
4
Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins.中东呼吸综合征冠状病毒——2012-2022 年全球人类和骆驼感染、基因组序列、谱系和地理起源的 10 年分析。
Int J Infect Dis. 2023 Jun;131:87-94. doi: 10.1016/j.ijid.2023.03.046. Epub 2023 Mar 29.
5
Spatiotemporal Clustering of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Incidence in Saudi Arabia, 2012-2019.2012-2019 年沙特阿拉伯中东呼吸综合征冠状病毒(MERS-CoV)发病率的时空聚集性。
Int J Environ Res Public Health. 2019 Jul 15;16(14):2520. doi: 10.3390/ijerph16142520.
6
Limited Genetic Diversity Detected in Middle East Respiratory Syndrome-Related Coronavirus Variants Circulating in Dromedary Camels in Jordan.在约旦流行的中东呼吸综合征相关冠状病毒变异体中检测到有限的遗传多样性。
Viruses. 2021 Mar 31;13(4):592. doi: 10.3390/v13040592.
7
Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study.沙特阿拉伯中东呼吸综合征冠状病毒疫情:一项回顾性研究。
BMC Infect Dis. 2017 Jan 5;17(1):23. doi: 10.1186/s12879-016-2137-3.
8
Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates.阿联酋阿布扎比酋长国单峰骆驼中东呼吸综合征冠状病毒(MERS-CoV)的流行情况
Virus Genes. 2015 Jun;50(3):509-13. doi: 10.1007/s11262-015-1174-0. Epub 2015 Feb 5.
9
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges.MERS-CoV:流行病学、分子动力学、治疗学及未来挑战。
Ann Clin Microbiol Antimicrob. 2021 Jan 18;20(1):8. doi: 10.1186/s12941-020-00414-7.
10
Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study.沙特阿拉伯王国哈费尔巴廷市中东呼吸综合征冠状病毒的社区病例聚集:一项描述性基因组研究
Int J Infect Dis. 2014 Jun;23:63-8. doi: 10.1016/j.ijid.2014.03.1372. Epub 2014 Mar 31.

引用本文的文献

1
MERS-CoV antagonizes PKR activation by inhibiting its condensation at viral replication complexes.中东呼吸综合征冠状病毒通过抑制蛋白激酶R(PKR)在病毒复制复合体处的聚集来拮抗其激活。
bioRxiv. 2025 Aug 22:2025.08.18.670656. doi: 10.1101/2025.08.18.670656.
2
Inhibitor-induced dimerization mediates lufotrelvir resistance in mutants of SARS-CoV-2 3C-like protease.抑制剂诱导的二聚化介导了严重急性呼吸综合征冠状病毒2 3C样蛋白酶突变体对鲁伏特韦的耐药性。
Protein Sci. 2025 Sep;34(9):e70275. doi: 10.1002/pro.70275.
3
Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism.

本文引用的文献

1
The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections.跨物种溢出感染导致的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与中东呼吸综合征冠状病毒(MERS-CoV)之间的重组潜力
J Epidemiol Glob Health. 2021 Jun;11(2):155-159. doi: 10.2991/jegh.k.201105.001. Epub 2020 Nov 23.
2
Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016.2011-2016 年沙特阿拉伯西部健康成年人中东呼吸综合征冠状病毒血清流行率。
J Infect Public Health. 2020 May;13(5):697-703. doi: 10.1016/j.jiph.2020.01.001. Epub 2020 Jan 28.
3
Middle East Respiratory Syndrome Coronavirus Transmission.
人鼻上皮多纤毛细胞中DPP4表达的变化作为中东呼吸综合征冠状病毒嗜性的决定因素。
Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2410630122. doi: 10.1073/pnas.2410630122. Epub 2025 Mar 6.
4
Low-Level Zoonotic Transmission of Clade C MERS-CoV in Africa: Insights from Scoping Review and Cohort Studies in Hospital and Community Settings.非洲C型中东呼吸综合征冠状病毒的低水平人畜共患传播:来自医院和社区环境范围审查及队列研究的见解
Viruses. 2025 Jan 17;17(1):125. doi: 10.3390/v17010125.
5
The Use of Next-Generation Sequencing in Personalized Medicine.下一代测序在个性化医疗中的应用。
Methods Mol Biol. 2025;2866:287-315. doi: 10.1007/978-1-0716-4192-7_16.
6
Saudi Arabia's Middle East respiratory syndrome Coronavirus (MERS-CoV) outbreak: consequences, reactions, and takeaways.沙特阿拉伯中东呼吸综合征冠状病毒(MERS-CoV)疫情:后果、反应及启示
Ann Med Surg (Lond). 2024 Jul 1;86(8):4668-4674. doi: 10.1097/MS9.0000000000002336. eCollection 2024 Aug.
7
Aerosol transmission of human pathogens: From miasmata to modern viral pandemics and their preservation potential in the Anthropocene record.人类病原体的气溶胶传播:从瘴气到现代病毒性大流行及其在人类世记录中的保存潜力。
Geosci Front. 2022 Nov;13(6):101282. doi: 10.1016/j.gsf.2021.101282. Epub 2021 Aug 11.
8
The use of next-generation sequencing in personalized medicine.下一代测序技术在个性化医疗中的应用。
ArXiv. 2024 Mar 6:arXiv:2403.03688v1.
9
Nasopharyngeal angiotensin converting enzyme 2 (ACE2) expression as a risk-factor for SARS-CoV-2 transmission in concurrent hospital associated outbreaks.鼻咽血管紧张素转换酶 2(ACE2)表达作为医院相关暴发中 SARS-CoV-2 传播的危险因素。
BMC Infect Dis. 2024 Feb 26;24(1):262. doi: 10.1186/s12879-024-09067-9.
10
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms.探索泛冠状病毒疫苗:新一代疫苗设计和免疫机制。
Cell Mol Immunol. 2024 Feb;21(2):103-118. doi: 10.1038/s41423-023-01116-8. Epub 2023 Dec 26.
中东呼吸综合征冠状病毒传播。
Emerg Infect Dis. 2020 Feb;26(2):191-198. doi: 10.3201/eid2602.190697.
4
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.世界卫生组织研发蓝图:需要紧急研发努力的新发传染病 2018 年审查。
Antiviral Res. 2018 Nov;159:63-67. doi: 10.1016/j.antiviral.2018.09.009. Epub 2018 Sep 24.
5
Middle East respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, alpacas and camels.自然接触过中东呼吸综合征冠状病毒的以色列美洲驼、羊驼和骆驼体内的特异性抗体
One Health. 2018 May 4;5:65-68. doi: 10.1016/j.onehlt.2018.05.002. eCollection 2018 Jun.
6
Nextstrain: real-time tracking of pathogen evolution.Nextstrain:实时追踪病原体进化。
Bioinformatics. 2018 Dec 1;34(23):4121-4123. doi: 10.1093/bioinformatics/bty407.
7
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission.中东呼吸综合征冠状病毒:原发性、家庭和医院传播的风险因素和决定因素。
Lancet Infect Dis. 2018 Aug;18(8):e217-e227. doi: 10.1016/S1473-3099(18)30127-0. Epub 2018 Apr 18.
8
TreeTime: Maximum-likelihood phylodynamic analysis.TreeTime:最大似然系统发育动力学分析。
Virus Evol. 2018 Jan 8;4(1):vex042. doi: 10.1093/ve/vex042. eCollection 2018 Jan.
9
MERS-CoV spillover at the camel-human interface.MERS-CoV 在骆驼-人类界面的溢出。
Elife. 2018 Jan 16;7:e31257. doi: 10.7554/eLife.31257.
10
MERS-coronavirus: From discovery to intervention.中东呼吸综合征冠状病毒:从发现到干预
One Health. 2016 Dec 23;3:11-16. doi: 10.1016/j.onehlt.2016.12.001. eCollection 2017 Jun.